Disease Activity in Pregnant and Postpartum Women With MS Receiving Ocrelizumab or Other Disease-Modifying Therapies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies
Neurol Neuroimmunol Neuroinflamm 2024 Nov 01;11(6)e200328, WZ Yeh, A Van Der Walt, OG Skibina, T Kalincik, R Alroughani, AG Kermode, MJ Fabis-Pedrini, WM Carroll, J Lechner-Scott, C Boz, S Ozakbas, K Buzzard, M Habek, NA John, A Prat, M Girard, P Duquette, SM Baghbanian, S Hodgkinson, V Van Pesch, G Laureys, B Willekens, J Prevost, M Foschi, K De Gans, D Horakova, EK Havrdova, R Karabudak, F Patti, PA Mccombe, D Maimone, A Altintas, R Ampapa, D Spitaleri, OHH Gerlach, MJ Sa, S Hughes, R Gouider, S Mrabet, RA Macdonell, R Turkoglu, E Cartechini, A Al-Asmi, A Soysal, J Oh, E Muros-Le Rouzic, S Guye, N Pasquarelli, H Butzkueven, VG JokubaitisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.